Lifeway Foods, Inc. (LWAY) AI Stock Analysis

Lifeway Foods, Inc. specializes in the production and global distribution of probiotic-based products for health-conscious consumers. Its primary offering is drinkable kefir, a cultured dairy beverage sold in organic and non-organic varieties, various fat levels, protein-enriched formulas, and BioKefir options. Its catalog also includes European-style soft cheeses, creams, ProBugs kefir for children, cupped kefir, Icelandic Skyr, and frozen kefir in pints and soft serve. Founded in 1986 and based in Morton Grove, Illinois, the company sells under the Lifeway and Fresh Made brands, as well as private labels, via a direct sales force, brokers, and distributors.

Annual revenue grew consistently from $119.1M in FY2021 to $212.5M in FY2025, reflecting a 13.7% increase in FY2025 and a 5-year CAGR of 15.8%. Gross margin improved to 27.4% in FY2025, up from 24.1% in FY2021 and 18.9% in FY2022. Net income rose from $3.3M in FY2021 to $13.9M in FY2025, bringing diluted EPS to $0.90. For the trailing twelve months, revenue reached $242.4M with a net profit margin of 4.5% and EPS of $0.69. In the latest quarter ended June 30, 2026, revenue increased 24.1% year-over-year, but quarterly earnings declined 97.0%, while operating margin for the trailing twelve months stood at 0.9%.

As of June 30, 2026, Lifeway Foods held $7.1M in cash and short-term investments alongside total debt of $22.6M, resulting in net debt of $15.5M. The company maintains a current ratio of 2.09, debt-to-equity of 0.27, and shareholders' equity of $84.6M against total assets of $132.4M. In FY2025, operating cash flow was $10.9M, but capital expenditures of $27.4M resulted in free cash flow of -$16.4M. Over the past 5 years, share count decreased by 0.9%.

Lifeway Foods trades at a trailing P/E of 32.0x and a forward P/E of 29.9x, both higher than the median of its US-listed Consumer Defensive peers, which sit at 18.6x and 14.3x, respectively. Its enterprise value of $370.7M reflects an EV/EBITDA multiple of 18.5x, above the peer median of 11.7x, while its price-to-sales of 1.4x exceeds the peer median of 0.7x. Over the past year, the stock returned -19.0%, underperforming the S&P 500 (SPY) return of 16.8%, though its 5-year return of 298.4% exceeded the index's 83.0%.

Wall Street coverage includes 3 Strong Buy ratings with no Buy, Hold, Sell, or Strong Sell recommendations. The mean price target is $33.00, representing 49.4% upside compared to the last close of $22.09. For the current fiscal year ending December 31, 2026, consensus estimates project revenue of $262.6M and EPS of $0.50, a 39.3% drop. For the next fiscal year, 1 analyst estimates revenue of $298.4M and EPS of $1.35. The company beat EPS estimates in 1 of the last 4 quarters, with its next earnings date set for November 11, 2026.

This page is an AI-written research summary of Lifeway Foods, Inc. (LWAY). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: LWAY income statement, LWAY balance sheet, LWAY key metrics, LWAY analyst forecast, LWAY chart. See the LWAY stock overview for the latest quote and news.